ArticleTrials2021

Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).

Barbara Soria-Juan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.